AU2012250497C1 - Prenylated hydroxystilbenes - Google Patents

Prenylated hydroxystilbenes Download PDF

Info

Publication number
AU2012250497C1
AU2012250497C1 AU2012250497A AU2012250497A AU2012250497C1 AU 2012250497 C1 AU2012250497 C1 AU 2012250497C1 AU 2012250497 A AU2012250497 A AU 2012250497A AU 2012250497 A AU2012250497 A AU 2012250497A AU 2012250497 C1 AU2012250497 C1 AU 2012250497C1
Authority
AU
Australia
Prior art keywords
och
chc
chch
ch2ch
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012250497A
Other languages
English (en)
Other versions
AU2012250497B2 (en
AU2012250497A1 (en
Inventor
Colin Charles Duke
Rujee Kyokajee DUKE
Van Hoan Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kynan Duke IP LLC
Original Assignee
Kynan Duke IP LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011901663A external-priority patent/AU2011901663A0/en
Application filed by Kynan Duke IP LLC filed Critical Kynan Duke IP LLC
Priority to AU2012250497A priority Critical patent/AU2012250497C1/en
Publication of AU2012250497A1 publication Critical patent/AU2012250497A1/en
Publication of AU2012250497B2 publication Critical patent/AU2012250497B2/en
Application granted granted Critical
Publication of AU2012250497C1 publication Critical patent/AU2012250497C1/en
Assigned to Kynan Duke IP, LLC reassignment Kynan Duke IP, LLC Request for Assignment Assignors: THE UNIVERSITY OF SYDNEY
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/235—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/253—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • C07C39/215—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring containing, e.g. diethylstilbestrol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2012250497A 2011-05-04 2012-05-04 Prenylated hydroxystilbenes Active AU2012250497C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012250497A AU2012250497C1 (en) 2011-05-04 2012-05-04 Prenylated hydroxystilbenes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2011901663 2011-05-04
AU2011901663A AU2011901663A0 (en) 2011-05-04 Prenylated Hydroxystilbenes
PCT/AU2012/000482 WO2012149608A1 (en) 2011-05-04 2012-05-04 Prenylated hydroxystilbenes
AU2012250497A AU2012250497C1 (en) 2011-05-04 2012-05-04 Prenylated hydroxystilbenes

Publications (3)

Publication Number Publication Date
AU2012250497A1 AU2012250497A1 (en) 2013-11-28
AU2012250497B2 AU2012250497B2 (en) 2016-04-14
AU2012250497C1 true AU2012250497C1 (en) 2016-09-29

Family

ID=47107689

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012250497A Active AU2012250497C1 (en) 2011-05-04 2012-05-04 Prenylated hydroxystilbenes

Country Status (13)

Country Link
US (4) US10196335B2 (enExample)
EP (1) EP2709975B1 (enExample)
JP (2) JP6297485B2 (enExample)
KR (1) KR101907716B1 (enExample)
CN (2) CN107266297B (enExample)
AU (1) AU2012250497C1 (enExample)
CA (1) CA2833780C (enExample)
DK (1) DK2709975T3 (enExample)
ES (1) ES2909403T3 (enExample)
IL (1) IL229204A (enExample)
PT (1) PT2709975T (enExample)
SG (2) SG194582A1 (enExample)
WO (1) WO2012149608A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG194582A1 (en) * 2011-05-04 2013-12-30 Univ Sydney Prenylated hydroxystilbenes
US9642829B2 (en) * 2012-12-04 2017-05-09 The University Of Hong Kong Antifungal compound and uses thereof
FR3030511B1 (fr) * 2014-12-22 2018-04-06 L'oreal Composes 1-phenyl (3,4,5-trisubstitues), 2-phenyl (3,5-disubstitues) ethylene et leur utilisation.
FR3030508B1 (fr) * 2014-12-22 2017-06-23 Oreal Composes 1-phenyl (3,4-disubstitues) 2-phenyl (3,5-disubstitues) ethylene et leur utilisation
FR3030510B1 (fr) 2014-12-22 2017-02-03 Oreal Composes 1-phenyl (3,4-disubstitues), 2-phenyl (3,4-disubstitues) ethane et leur utilisation
CN109952095B (zh) * 2016-09-07 2022-05-03 凯楠公爵Ip有限责任公司 细齿烷二萜类的药物用途
CN110183414B (zh) * 2019-07-25 2019-10-25 江西中医药大学 二色波罗蜜中的一种异戊烯基二苯乙烯及其在制备治疗炎症性疾病药物中的用途
CN110183311B (zh) * 2019-07-25 2019-10-29 江西中医药大学 一种异戊烯基芪及其在制备治疗炎症性疾病药物中的用途
IL294179B2 (en) * 2019-12-23 2026-04-01 Kynan Duke Ip Llc Modified hydroxystilbene compounds, their derivatives, method for their preparation and use.
CN111579682A (zh) * 2020-05-29 2020-08-25 山东师范大学 一种针对不同蜂胶产品差异性代谢物的分析方法及其应用
CN114573430B (zh) * 2022-03-10 2022-09-06 中国科学院华南植物园 一种甘草抗炎物质及其制备方法
JP7614652B2 (ja) * 2022-08-12 2025-01-16 株式会社山田養蜂場本社 ステロイド－５α－リダクターゼ阻害剤
JP7849021B2 (ja) * 2022-09-14 2026-04-21 株式会社山田養蜂場本社 Ｓｉｒｔ１活性化剤
WO2024249297A2 (en) * 2023-05-26 2024-12-05 Cambium Biomaterials, Inc. Polymeric compositions with prenylated stilbenes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010121A1 (en) * 2001-07-23 2003-02-06 Pacific Corporation Stilbene derivatives, a method for preparation thereof, and its use
US20030125377A1 (en) * 2001-08-07 2003-07-03 Kinghorn Alan Douglas Aromatase inhibitors from Broussonetia papyrifera

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717859A (ja) 1993-06-30 1995-01-20 Tsumura & Co アラキドン酸代謝異常疾患治療剤
KR20030011980A (ko) 2001-07-23 2003-02-12 주식회사 태평양 스틸벤 유도체를 유효성분으로 포함하는 과색소 침착치료용 의약 조성물
WO2003009807A2 (en) 2001-07-23 2003-02-06 Galileo Laboratories, Inc. Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
CN100342862C (zh) * 2003-06-27 2007-10-17 中国医学科学院药物研究所 白藜芦醇低聚茋类化合物及其制法和其药物组合物与用途
GB2411353A (en) 2004-02-25 2005-08-31 Univ Hertfordshire Resveratrol Analogues
CN1331856C (zh) * 2005-08-05 2007-08-15 大连理工大学 多羟基茋类化合物的制备和抑制sars病毒药物的用途
US7781580B2 (en) * 2007-04-23 2010-08-24 Virginia Commonwealth University Stilbene derivatives as new cancer therapeutic agents
CN100503539C (zh) * 2007-06-14 2009-06-24 复旦大学 一种具有抗肿瘤活性的二苯乙烯类化合物及其制备方法
WO2009012910A1 (en) 2007-07-20 2009-01-29 Universita'degli Studi Di Milano Biologically-active stilbene derivatives and compositions thereof
JP2012503595A (ja) * 2008-07-28 2012-02-09 シダンスク ユニバーシティ 代謝病の治療用の化合物
US20130310611A1 (en) * 2010-10-28 2013-11-21 Uha Mikakuto Co., Ltd. Process for production of phenolic polymerizable compound having physiological activity
US9340477B2 (en) * 2010-11-26 2016-05-17 Uha Mikakuto Co., Ltd. Process for production of hydroxystilbene derivative having physiological activity
SG194582A1 (en) * 2011-05-04 2013-12-30 Univ Sydney Prenylated hydroxystilbenes
JP7017859B2 (ja) 2017-03-21 2022-02-09 日鉄鋼板株式会社 建築パネル

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010121A1 (en) * 2001-07-23 2003-02-06 Pacific Corporation Stilbene derivatives, a method for preparation thereof, and its use
US20030125377A1 (en) * 2001-08-07 2003-07-03 Kinghorn Alan Douglas Aromatase inhibitors from Broussonetia papyrifera

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHENG-PO HUANG ET AL: "Arachidin-1, a Peanut Stilbenoid, Induces Programmed Cell Death in Human Leukemia HL-60 Cells", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol . 58, no. 23, 8 December 2010, pages 12123-12129 *
FUKAI T ET AL: "CYTOTOXIC ACTIVITY OF LOW MOLECULAR WEIGHT POL YPHENOLS AGAINST HUMAN ORAL TUMOR CELL LINES", ANTICANCER RESEARCH - INTERNATIONAL JOURNAL OF CANCER RESEARCH AND TREATMENT, vol. 20, no. 4, 1 January 2000, pages 2525-2536, *
Kusano G. ET AL: "Studies on Index Compounds for HPLC Analysis of Glycyrthiza Flavenscens Growing in Turkey", Natural Medicines, 56 (4), 1 January 2002, pages 129-135, *
ORSINI F. ET AL: "Resveratrol Derivatives and Their Role as Potassium Channels Modulators", JOURNAL OF NATURAL PRODUCTS, vol. 67, no. 3, 1 March 2004 (2004-03-01 ), pages 421-426 *

Also Published As

Publication number Publication date
EP2709975A4 (en) 2014-12-17
ES2909403T3 (es) 2022-05-06
WO2012149608A1 (en) 2012-11-08
SG10201603776RA (en) 2016-07-28
AU2012250497B2 (en) 2016-04-14
AU2012250497A1 (en) 2013-11-28
CA2833780C (en) 2020-10-06
NZ616960A (en) 2016-01-29
US20150307429A1 (en) 2015-10-29
JP6461398B2 (ja) 2019-01-30
CN107266297A (zh) 2017-10-20
US20220380285A1 (en) 2022-12-01
US20190194105A1 (en) 2019-06-27
IL229204A (en) 2016-11-30
DK2709975T3 (da) 2022-03-21
WO2012149608A8 (en) 2013-11-14
JP6297485B2 (ja) 2018-03-20
KR101907716B1 (ko) 2018-10-12
IL229204A0 (en) 2014-01-30
KR20140043369A (ko) 2014-04-09
US11352310B2 (en) 2022-06-07
CN107266297B (zh) 2020-10-16
US11634375B2 (en) 2023-04-25
EP2709975A1 (en) 2014-03-26
EP2709975B1 (en) 2022-01-12
JP2018127454A (ja) 2018-08-16
SG194582A1 (en) 2013-12-30
CN103649031A (zh) 2014-03-19
US10696615B2 (en) 2020-06-30
PT2709975T (pt) 2022-03-31
US20200331833A1 (en) 2020-10-22
US10196335B2 (en) 2019-02-05
CA2833780A1 (en) 2012-11-08
JP2014519488A (ja) 2014-08-14

Similar Documents

Publication Publication Date Title
US11634375B2 (en) Prenylated hydroxystilbenes
Singh et al. Synthesis and anti-proliferative activities of new derivatives of embelin
Feng et al. Polyisoprenylated benzophenone derivatives from Garcinia cambogia and their anti-inflammatory activities
Mulula et al. Synthesis, In-vitro antibacterial and antioxidant activity of chalcone derivatives
JP7064094B2 (ja) セルラタンジテルペンの医薬用途
JP4847014B2 (ja) 治療化合物および方法
NZ616960B2 (en) Prenylated hydroxystilbenes
KR101704898B1 (ko) 신선초로부터 분리된 신규 화합물 및 상기 화합물을 포함하는 유독성 약물 또는 방사선 조사에 의한 세포 손상의 예방 또는 치료용 조성물
HK1191929B (en) Prenylated hydroxystilbenes
RU2411229C2 (ru) Терапевтические хиноны
JP7405855B2 (ja) 生理活性化合物
US20100144857A1 (en) Prenylflavanone compounds and uses thereof
US20100144856A1 (en) Prenylfavanone compounds and uses thereof
BRPI0803375A2 (pt) compostos derivados de 4-hidroxi-3-metoxi-benzaldeìdo, processo de obtenção, composição farmacêutica, uso de um ou mais compostos

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 21 JUN 2016 .

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 05 AUG 2016

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 05 AUG 2016 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 21 JUN 2016

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: KYNAN DUKE IP, LLC

Free format text: FORMER OWNER(S): THE UNIVERSITY OF SYDNEY